Aliada brings AbbVie an early clinical Alzheimer’s disease drug candidate as well as the platform technology that produced it. Aliada licensed its brain delivery technology from Johnson & Johnson. The post AbbVie Adds Another Alzheimer’s Prospect With $1.4B Aliada Therapeutics Acquisition appeared first on MedCity News.
The healthcare industry’s inability to coordinate care effectively and at scale is the single biggest issue in the sector, said Tampa General Hospital CEO John Couris. The post This Problem Keeps Hospital Execs Up at Night, Tampa General Hospital CEO Says appeared first on MedCity News.
HealthJoy and Mark Cuban Cost Plus Drug Company have teamed up. Through the partnership, HealthJoy can now direct the employees of its clients to the drug company when it offers a cheaper option for generic drugs. The post HealthJoy, Cost Plus Drugs Partner To Reduce Drug Costs for Employers appeared first on MedCity News.
Novartis is getting global rights to a Monte Rosa Therapeutic molecular glue degrader drug in early clinical testing as a potential treatment for autoimmune disorders. The deal comes months after the pharma giant landed rights to an Arvinas targeted protein degrader for cancer. The post Novartis to Pay $150M for Monte Rosa Glue Drug in…
To fully capitalize on its potential, laboratories must ensure they understand how to use AI effectively. Without this understanding, there’s a risk of undermining the technology’s benefits and potentially harming the industry as a whole. The post Harnessing AI in Pathology: A Vital Tool That Requires Careful Ownership appeared first on MedCity News.
Clearinghouses are just one great example of how the enhanced exchange of healthcare data can increase efficiency for healthcare providers and the greater healthcare community. The post Increasing Efficiency and Reimbursements with Clearinghouses appeared first on MedCity News.
Seaport Therapeutics’ Series B financing was one of the largest rounds of funding in our recap of biotech financing news, which spans startups developing drugs for neurological diseases, cancer, immunology, and more. The post Seaport Therapeutics Secures $225M for New Kind of Depression Drug appeared first on MedCity News.
We should use AI to develop recommendations for breast cancer screening protocols based on quantified risk, factoring in family history, ethnicity, genetics, and density, et al. – and then support the use of powerful new imaging AI technologies for those cases that demand a deeper look. The post Navigating the Breast Cancer Screening Debate: The…
At HLTH 2024, I had dozens of conversations with providers, investors and digital health startup executives. Here are seven refreshingly honest takes I heard from them. The post 7 Hot Takes I Heard at HLTH appeared first on MedCity News.
The new standards emphasize the need for strong reporting and analytics that go beyond just credentialing automation. Healthcare organizations must look for solutions with comprehensive self-serve reporting capabilities to improve access and visibility into activities like potential changes to data, monitoring gaps, and more. The post NCQA’s Updated 2025 Standards Have Published: What it Means…